CLEVELAND CLINIC FOUNDATION for CLEVELAND CLINIC FOUNDATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Telecommunications TEC
Issues related to the application of the internet to healthcare. Issues related to the use of telehealth technologies in patient care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
Health Issues HCR
Advancing Care for Exceptional (ACE) Kids Act (H.R. 546); provisions related to the care of medically complex pediatric patients. Stop OD Act (H.R. 5432), and other Opiate issues; general issues related to the role of clinical providers in the care of addicted patients. Never Again Act (H.R. 6108); provisions related to non-department facilities. Issues related to supporting organ donation. Early Hearing Detection and Intervention Act (S.2424); generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
Medicare/Medicaid MMM
Helping Hospitals Improve Patient Care Act (H.R. 5273); provisions related to Medicare Part B in outpatient facilities/HOPD reimbursement. Issues surrounding prior authorization of surgical care. Bipartisan Budget Act of 2015 (H.R. 1314), Sec 603; provisions related to hospital outpatient reimbursements. FY 2017 Outpatient Prospective Payment System proposed and final rules. Hospital Quality Rating Transparency Act (H.R. 5927); provisions related to hospital quality reporting. Independence at Home Act of 2016 (S. 3130); general issues related to bill content. Issues related to the reimbursement of cancer care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
| KRISTEN DW MORRIS | — |
| ELIZABETH SUMP | — |
Budget/Appropriations BUD
Fiscal Year 2017 Labor, Health and Human Services Funding Bill; general content of legislation. FY 2017 Defense Appropriations Bill; provisions related to research funding. General issues related to medical research. .
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
| KRISTEN DW MORRIS | — |
| ELIZABETH SUMP | — |
Pharmacy PHA
Increasing Competition in Pharmaceuticals Act (S. 2615); issues related to drug shortages and prices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
Medical/Disease Research/Clinical Labs MED
Issues related to the funding of diabetes research and care. The 21st Century Cures Act (H.R. 6); issues surrounding teleheath, interoperability, and research funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLOS JACKSON | — |
| GINA PETREDIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.